Profit

Marketing nod for Itolizumab a milestone: Kiran Mazumdar-Shaw

PUBLISHED ON: January 8, 2013 | Duration: 3 min, 44 sec

  
loading..
In conversation with NDTV, Kiran Mazumdar-Shaw of Biocon says that the marketing nod that the company has got for biologic Itolizumab is another milestone cleared and that the company intends to start marketing the drug in India during 2013.
ALSO WATCH
"Government Trusts Bureaucrats Over Businessmen": Kiran Mazumdar Shaw To NDTV

................................ Advertisement ................................

................................ Advertisement ................................